reference/29074987

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/29074987

Outgoing Links

Predicate	Object
contentType	Journal Article
issn	1471-2407
issueIdentifier	1
pageRange	423-
publicationName	BMC Cancer
startingPage	423
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_a1ebfe17b0713ecaf89801f0370c078d http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_ca5af3fd79e89df5cc8b9aa5a93f7e59 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_be96cf2f5a49f603276591a8063549b8
bibliographicCitation	Georgescu C, Corbin JM, Thibivilliers S, Webb ZD, Zhao YD, Koster J, Fung KM, Asch AS, Wren JD, Ruiz-Echevarría MJ. A TMEFF2-regulated cell cycle derived gene signature is prognostic of recurrence risk in prostate cancer. BMC Cancer. 2019 May 06;19(1):423. PMID: 31060542; PMCID: PMC6503380.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_232bf9c7d338bf6e5e6626d86b111a17 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_32257b0faf9068ea1d3aaabccd26428e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_049ed037f9075a28b84023e69267a959 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f5c0eb4e9bc4605de9eb6cb893f9be54 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-7133-9982 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9dd35b3d1a2bb69e41ac443a3f91b4dc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fc95783e615958beab4a817bbb00daf2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8ab1e148a9f3b31a8e87190abd25564a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_74df3a3a126c89d229c299e9c0a2ef03 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0496118d11f3f2b8b8645d1f34febc05
date	2019-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/31060542 https://doi.org/10.1186/s12885-019-5592-6 https://pubmed.ncbi.nlm.nih.gov/PMC6503380
isPartOf	https://portal.issn.org/resource/ISSN/1471-2407 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/22020
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://scigraph.springernature.com/ https://www.crossref.org/
title	A TMEFF2-regulated cell cycle derived gene signature is prognostic of recurrence risk in prostate cancer
discusses	http://id.nlm.nih.gov/mesh/M0014578 http://id.nlm.nih.gov/mesh/M0013341 http://id.nlm.nih.gov/mesh/M0022149 http://id.nlm.nih.gov/mesh/M0383924 http://id.nlm.nih.gov/mesh/M0019167
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11431 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8983 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_9e6bfb4e0fb0cf1fbd08d6aece991a09 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5995

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID23671

Total number of triples: 43.